Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-02-20Clinical Trial Update: Blood Test for Ovarian Cancer Associated Auto Antibodies
A clinical trial update on a blood test by Eventus Diagnostics Ltd to detect autoantibodies associated with ovarian cancer; current status i…
-
CLINICAL_TRIALS research · 2014-02-14Clinical Trial Update: Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
This clinical trial update describes strategies being developed to increase enrollment of pediatric cancer patients in clinical trials.
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update covers a phase 1/2 study of combination chemotherapy with peripheral stem cell transplantation for recurrent or p…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating platinum-based chemotherapy with or without paclitaxel for relapsed ovarian cancer and primary peritonea…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of squalamine lactate and carboplatin for recurrent or refractory stage III/IV ovaria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer [Phase 3]
A Phase 3 trial comparing adjuvant chemotherapy versus observation in patients with resected early-stage ovarian epithelial cancer; the curr…
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors [Phase 2]
Phase 2 clinical trial update on combination chemotherapy for pediatric metastatic rhabdomyosarcoma and other malignant mesenchymal tumors; …
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating a monoclonal antibody therapy in patients with residual disease after surgery and chemotherapy for stage I…
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]
This entry reports an ongoing Phase 2 clinical trial evaluating the combination of IM-862 with chemotherapy for patients with resected stage…
-
CLINICAL_TRIALS research · 2013-11-01Clinical Trial Update: Hypodontia and Ovarian Cancer
Clinical trial update from the University of Aarhus involves ovarian cancer and hypodontia, with related conditions including breast cancer …
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer [Phase 2]
Phase 2 clinical trial update evaluating sequential chemotherapy for patients with residual disease after surgery for advanced ovarian cance…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
This clinical trial update describes a laboratory study aimed at predicting tumor response to chemotherapy in patients with fallopian tube c…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Feeding Schedules After Surgery in Patients With Gynecologic Cancer [NA]
An update on a clinical trial investigating feeding schedules after surgery in patients with gynecologic cancer. The current status is liste…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors [NA]
This clinical trial update describes the etoposide, carboplatin, and bleomycin regimen being studied in young patients undergoing surgery fo…
-
CLINICAL_TRIALS research · 2013-09-17Clinical Trial Update: Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating two different schedules of carboplatin, paclitaxel, and gemcitabine with surgery for newly diagnosed adv…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer [Phase 2]
Phase 2 trial comparing carboplatin with or without thalidomide in ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer [NA]
This clinical trial update describes a study investigating whether DNA mutations can predict the effect of external-beam radiation therapy i…
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer [Phase 2]
This entry covers a Phase 2 trial of paclitaxel and cisplatin as first-line therapy for ovarian epithelial cancer across stages I-IV.
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
A Cancer Research UK study update describes a trial investigating genetic and environmental factors in patients with ovarian cancer in the E…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy for stage II, stage III, or stage IV ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2, Phase 3]
This entry describes a Phase 2/3 clinical trial evaluating combination chemotherapy with or without whole-body hyperthermia in patients with…
-
CLINICAL_TRIALS research · 2013-07-31Clinical Trial Update: Elecsys HE4 Chinese Reference Value Study
Clinical trial assessing reference values for the HE4 biomarker (Elecsys HE4) in a Chinese population with ovarian cancer; the study status …
-
CLINICAL_TRIALS research · 2013-06-27Clinical Trial Update: Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve [NA]
This clinical trial update compares salpingectomy with tubal sterilisation in women at low risk for ovarian cancer and assesses the effect o…
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum [Phase 2]
A Phase 2 trial evaluating the combination of bicalutamide and goserelin in ovarian cancer, fallopian tube cancer, or primary peritoneal can…
-
CLINICAL_TRIALS research · 2013-06-10Clinical Trial Update: Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer [NA]
Clinical trial to screen individuals at high genetic risk for ovarian cancer, sponsored by Massachusetts General Hospital. The trial status …